Kymera Therapeutics, Inc. (KYMR)

85.40 +0.47 (+0.55%) USD  |  NASDAQ  |  Apr 02, 16:00
85.34 -0.06 (-0.07%) After-Hours: 20:00
More

Kymera Therapeutics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Revolution Medicines, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade